Clonal Evolutionary Analysis during HER2 Blockade in HER2-Positive Inflammatory Breast Cancer: A Phase II Open-Label Clinical Trial of Afatinib +/- Vinorelbine.

Gerald GohRamona SchmidKelly GuiverWichit ArpornwiratImjai ChitapanaruxVinod GanjuSeock-Ah ImSung-Bae KimArunee DechaphunkulJedzada ManeechavakajornNeil SpectorThomas YauMehdi AfritSlim Ben AhmedStephen R JohnstonNeil GibsonSung-Bae KimJavier HerreroCharles Swanton

Published in: PLoS medicine (2016)

ClinicalTrials.gov NCT01325428.

Keyphrases

phase ii
open label
clinical trial
phase ii study
phase iii
study protocol
placebo controlled
double blind
oxidative stress
gene expression
randomized controlled trial
genome wide
dna methylation
advanced non small cell lung cancer
radiation therapy
rectal cancer
young adults
breast cancer risk